Website intended for a NZ health professional readership
Clinical Rehabilitation Guideline for People with Long COVID in Aotearoa New Zealand
This guideline is intended to provide clinical guidance on long COVID conditions in both children and adults in Aotearoa New Zealand.
The guideline is an evidence-based summary that covers the definition and diagnosis of long COVID.
It seeks to provide the best evidence currently available to assist informed decision-making to improve the health, vocational and social outcomes for individuals with long COVID.
The guideline is intended for use by primary care practitioners, community and hospital clinicians, policy makers, funders, parents, carers, specialists, individuals with long COVID, whānau and any others who make provision for individuals with long COVID.
The factsheets have a summary of the resources available for individuals and clinicians.
The symptom map is a tool which has been created to assist with clinical assessment of individuals presenting with long COVID symptom.
The guideline can be accessed here
This article, written by Sidhesh Phaldessai, provides an overview of geriatric psychopharmacology, including the epidemiology of mental health disorders in the older population, the physiological changes that occur with ageing and their impact on pharmacokinetics and pharmacodynamics, and the use of psychotropic medications in older adults
Current clinical guidelines emphasise the significance of having two Adrenaline Auto-Injectors (AAIs) for individuals at risk of anaphylaxis.1*
